Skip to main content

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensitive detection of multiple genomic markers focused on oncology applications, utilizing Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology on Bio-Rad’s QX600 platform. Following regulatory clearance, Biodesix will manufacture and distribute dedicated specimen collection kits for the developed assays. The first assays to be validated under the agreement include...

Continue reading

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) U.S. Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) — via IBN — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts (“PharmacyChain™”) into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry....

Continue reading

DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

Strategic Alliance Targets Digital Transformation of the $634.32 Billion (1) U.S. Prescription Drug Market Through Blockchain-Enabled Data Monetization and AI-Driven Efficiency Gains BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) — via IBN — DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. (“Wellgistics”) (NASDAQ: WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts (“PharmacyChain™”) into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry....

Continue reading

Atos successfully deployed its advanced sport technologies for the World Para Swimming and World Para Athletics Championships in Asia

                 Atos successfully deployed its advanced sport technologies for the World Para Swimming and World Para Athletics Championships in Asia Paris, France, October 22, 2025 – Atos, a global leader of AI-powered digital transformation, announces today it has successfully delivered the essential services for two landmark Para Sports events taking place almost simultaneously in Asia: the World Para Swimming Championships Singapore 2025, and the World Para Athletics Championships New Delhi 2025, India. Atos has been managing the planning, preparation, orchestration, and operations of both events, providing competitors and stakeholders with an exceptional experience, reinforcing the values of inclusion, accessibility and sporting excellence. The World Para Swimming Championships Singapore 2025, hosted for the first time in Asia, took...

Continue reading

Chery Brand User Summit Stages Ultimate Safety Challenge: TIGGO9 Tackles the 15° Small-Overlap Collision with Taichi-Inspired Philosophy

WUHU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) — On October 18, an unprecedented test pushing the boundaries of automotive safety took place at the Chery Crash Test Center. As a key highlight of the 2025 Chery Brand User Summit, the “Ultimate Safety Exploration Tour” featured groundbreaking real-world collision scenarios. In the extreme test where two TIGGO9 vehicles collided at 50 km/h with a 15° overlap, Chery illustrated the true meaning of “Safety, for Family” and reaffirmed its commitment to “Let everyone enjoy five-star safety.”Teaser poster for Ultimate Safety Exploration Tour This challenge was not merely a display of technology, but an elevation of its core beliefs. At the 2025 Chery Brand User Summit, themed “Co-Create the New Move,” Chery presented a visually and intellectually...

Continue reading

Sky Quarry and Continuum Move Closer to Launching Real-World Asset Tokens and Exchange Platform

Partnership advances framework to simplify how investors access commodity-linked assets while expanding Sky Quarry’s capital options WOODS CROSS, Utah, Oct. 22, 2025 (GLOBE NEWSWIRE) — Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or the “Company”), an integrated energy solutions company committed to transforming the waste asphalt shingle recycling industry, today announced significant progress in its partnership with Continuum Network, accelerating work that began with the signing of a Memorandum of Understanding (MOU) in August 2025. Under the collaboration, Sky Quarry and Continuum are working to establish a clear framework for tokenizing energy-linked commodities and developing the digital infrastructure needed to support a modernized treasury model. Since signing the MOU, the parties have advanced both...

Continue reading

Elanders AB: Quarterly Report January – September 2025

January – September 2025Net sales amounted to MSEK 9,148 (10,369), which corresponded to an organic net sales reduction of three percent compared to the same period last year, excluding acquisitions and discontinued operations, and using unchanged exchange rates. Adjusted EBITA amounted to MSEK 510 (632), which equaled an adjusted EBITA margin of 5.6 (6.1) percent. Operating profit was impacted by one-off items of MSEK -185 (66), which mainly referred to structural measures to meet a weaker market and over time improve the Group’s margins. The structural measures are expected to result in annual cost savings of around MSEK 232, of which around MSEK 99 in 2025. Adjusted result after tax amounted to MSEK 38 (117), corresponding to SEK 0.98 (3.20) per share. Operating cash flow adjusted for purchase prices for acquisitions amounted to MSEK...

Continue reading

IMCD 2025 First Nine Months 2025 results webcast invitation

Rotterdam, The Netherlands (22 October 2025)  We are pleased to inform you that IMCD will publish its First Nine Months 2025 results on Thursday 6 November 2025 at 07.00 am CET. Following the publication, Marcus Jordan (CEO) and Hans Kooijmans (CFO) will host an analyst conference call & webcast starting at 09.00 am CET. The presentation will be made available on the publication date at 7:00 am CET on our website under the Investor Relations section. A replay of the webcast will be uploaded to our website shortly after the event. Webcast (prior registration required)You may register in advance for the webcast by clicking on the attend button here. Please note: viewers of the webcast will not be able to ask questions. Only the analyst conference call participants will have the opportunity to do so. Kind regards, Tosca HoltlandHead...

Continue reading

Correction: Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

Correction to company announcement in English: The English company announcement regarding the report for the first three quarters of 2025 incorrectly included figures from the half year. This announcement has now been updated with the correct figures of the first three quarters of 2025. The attached reports are unchanged.Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders 22 October 2025 Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025 The bank’s board of directors and general management today approved the report for the first three quarters of 2025. The bank delivers core earnings of DKK 2,321 million and net profit of DKK 1,753 million in the first three quarters of the year. The net profit is equivalent to a 21% p.a. return on equity.Core earnings(DKK million) Q1-Q3 2025 Q1-Q3 2024 2024 2023 2022 2021Total...

Continue reading

Solar A/S: No. 9 2025 Solar signs agreement to acquire Sonepar in Norway

Today, Solar Norge AS has signed an agreement with Sonepar Sverige AB to acquire 100% of Sonepar Norge AS. The transaction values Sonepar Norge at DKK 315m on an Enterprise Value basis. The transaction is not expected to have an impact on the Solar Group results in 2025 except for the expected acquisition costs of DKK 5m. The transaction will be financed through a combination of 1/3 equity financing via an accelerated bookbuilding and 2/3 debt financing. CEO Jens Andersen says:“The combination of Solar and Sonepar in Norway will be transformative for our Norwegian business by creating economies of scale in addition to improving our physical distribution channels with a strong network of branches. The strong operational and commercial synergies between the companies are expected to unlock significant opportunities to develop the combined...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.